These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 33756436)
21. Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients. Chbili C; Fathallah N; Laouani A; Nouira M; Hassine A; Ben Amor S; Ben Ammou S; Ben Salem C; Saguem S J Neurogenet; 2016 Mar; 30(1):16-21. PubMed ID: 27276192 [TBL] [Abstract][Full Text] [Related]
23. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy. Ma CL; Wu XY; Zheng J; Wu ZY; Hong Z; Zhong MK Pharmacogenomics; 2014 Jul; 15(10):1323-36. PubMed ID: 25155934 [TBL] [Abstract][Full Text] [Related]
24. SCN1A rs3812718 polymorphism is associated with epilepsy: An updated meta-analysis. Zhi H; Wu C; Yang Z Epilepsy Res; 2018 May; 142():81-87. PubMed ID: 29605548 [TBL] [Abstract][Full Text] [Related]
25. Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children: A protocol for systematic review and meta-analysis. Wen Z; Chen J; Zhu B; Lu Y; Chen L Medicine (Baltimore); 2021 May; 100(20):e25831. PubMed ID: 34011048 [TBL] [Abstract][Full Text] [Related]
26. Association between PK/PD-involved gene polymorphisms and carbamazepine-individualized therapy. Ma CL; Jiao Z; Wu XY; Hong Z; Wu ZY; Zhong MK Pharmacogenomics; 2015; 16(13):1499-512. PubMed ID: 26314341 [TBL] [Abstract][Full Text] [Related]
27. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis. Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570 [TBL] [Abstract][Full Text] [Related]
28. Association Between Li M; Zhong R; Lu Y; Zhao Q; Li G; Lin W Front Neurol; 2020; 11():591828. PubMed ID: 33519675 [No Abstract] [Full Text] [Related]
29. Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy. Zhu X; Yun W; Sun X; Qiu F; Zhao L; Guo Y Pharmacogenomics; 2014; 15(15):1867-79. PubMed ID: 25495409 [TBL] [Abstract][Full Text] [Related]
30. Effects of CYP3A5 and UGT2B7 variants on steady-state carbamazepine concentrations in Chinese epileptic patients. Lu Q; Huang YT; Shu Y; Xu P; Xiang DX; Qu Q; Qu J Medicine (Baltimore); 2018 Jul; 97(30):e11662. PubMed ID: 30045320 [TBL] [Abstract][Full Text] [Related]
31. Association of EPHX1 polymorphisms with plasma concentration of carbamazepine in epileptic patients: Systematic review and meta-analysis. Hu T; Zeng X; Tian T; Liu J J Clin Neurosci; 2021 Sep; 91():159-171. PubMed ID: 34373022 [TBL] [Abstract][Full Text] [Related]
32. Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients. Park PW; Seo YH; Ahn JY; Kim KA; Park JY J Clin Pharm Ther; 2009 Oct; 34(5):569-74. PubMed ID: 19744012 [TBL] [Abstract][Full Text] [Related]
33. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization. Hung CC; Chang WL; Ho JL; Tai JJ; Hsieh TJ; Huang HC; Hsieh YW; Liou HH Pharmacogenomics; 2012 Jan; 13(2):159-69. PubMed ID: 22188362 [TBL] [Abstract][Full Text] [Related]
34. SCN1A rs3812718 polymorphism and susceptibility to epilepsy with febrile seizures: a meta-analysis. Tang L; Lu X; Tao Y; Zheng J; Zhao P; Li K; Li L Gene; 2014 Jan; 533(1):26-31. PubMed ID: 24076350 [TBL] [Abstract][Full Text] [Related]
35. Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. Puranik YG; Birnbaum AK; Marino SE; Ahmed G; Cloyd JC; Remmel RP; Leppik IE; Lamba JK Pharmacogenomics; 2013 Jan; 14(1):35-45. PubMed ID: 23252947 [TBL] [Abstract][Full Text] [Related]
36. Polymorphisms of the sodium voltage-gated channel, alpha subunit 1 (SCN1A -A3184G) gene among children with non-lesional epilepsy: a case-control study. Ghazala E; Shahin DA; Wahba Y Ital J Pediatr; 2022 Sep; 48(1):157. PubMed ID: 36056404 [TBL] [Abstract][Full Text] [Related]
37. Association of Katsarou MS; Siatouni A; Tsikrika D; Kokkiou E; Stefanatou M; Verentzioti A; Alexoudi A; Gatzonis S; Drakoulis N; Papasavva M Genes (Basel); 2024 Sep; 15(9):. PubMed ID: 39336815 [No Abstract] [Full Text] [Related]
38. SCN1A and SCN1B gene polymorphisms and their association with plasma concentrations of carbamazepine and carbamazepine 10, 11 epoxide in Iranian epileptic patients. Namazi S; Azarpira N; Javidnia K; Emami M; Rahjoo R; Berahmand R; Borhani-Haghighi A Iran J Basic Med Sci; 2015 Dec; 18(12):1215-20. PubMed ID: 26877851 [TBL] [Abstract][Full Text] [Related]
39. Association between Genetic Polymorphism of Tang HX; Ho MD; Vu NP; Cao HV; Ngo VA; Nguyen VT; Nguyen TD; Nguyen TD Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674283 [No Abstract] [Full Text] [Related]
40. SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy. Ma CL; Wu XY; Jiao Z; Hong Z; Wu ZY; Zhong MK Pharmacogenomics; 2015; 16(4):347-60. PubMed ID: 25823783 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]